
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $269.8M | $317.9M | $362.6M | $355M | $306.5M | |
Revenue Growth (YoY) | -4.98% | 17.83% | 14.05% | -2.08% | -13.67% | |
Cost of Revenues | $165.5M | $192.8M | $213M | $204.7M | $181M | |
Gross Profit | $104.3M | $125.1M | $149.6M | $150.3M | $125.5M | |
Gross Profit Margin | 38.65% | 39.36% | 41.26% | 42.34% | 40.95% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $78.3M | $95.7M | $104.5M | $106.9M | $107.6M | |
Other Inc / (Exp) | -$6.6M | -$2.5M | $1.9M | -$2.7M | $431K | |
Operating Expenses | $78.3M | $95.7M | $104.5M | $106.9M | $107.6M | |
Operating Income | $26M | $29.4M | $45.1M | $43.5M | $18M | |
Net Interest Expenses | $1.1M | $978K | $1.9M | $2.3M | $839K | |
EBT. Incl. Unusual Items | $18.3M | $25.9M | $45.1M | $38.4M | $17.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $7.5M | $5.5M | $8.5M | $12.4M | $7.7M | |
Net Income to Company | $10.8M | $20.4M | $36.6M | $26M | $9.8M | |
Minority Interest in Earnings | -$13K | -$222K | -$490K | -$303K | $77K | |
Net Income to Common Excl Extra Items | $10.8M | $20.2M | $36.1M | $25.7M | $9.9M | |
Basic EPS (Cont. Ops) | $0.80 | $1.49 | $2.65 | $1.89 | $0.74 | |
Diluted EPS (Cont. Ops) | $0.79 | $1.48 | $2.63 | $1.88 | $0.74 | |
Weighted Average Basic Share | $13.6M | $13.6M | $13.6M | $13.6M | $13.4M | |
Weighted Average Diluted Share | $13.6M | $13.7M | $13.7M | $13.7M | $13.4M | |
EBITDA | $32.2M | $42.1M | $62.7M | $58M | $35.9M | |
EBIT | $19.7M | $27.1M | $47.4M | $42.4M | $20.1M | |
Revenue (Reported) | $269.8M | $317.9M | $362.6M | $355M | $306.5M | |
Operating Income (Reported) | $26M | $29.4M | $45.1M | $43.5M | $18M | |
Operating Income (Adjusted) | $19.7M | $27.1M | $47.4M | $42.4M | $20.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $70.6M | $87.7M | $88.9M | $80.8M | $71.7M | |
Revenue Growth (YoY) | 4.27% | 24.19% | 1.37% | -9.09% | -11.19% | |
Cost of Revenues | $42M | $52.4M | $51.7M | $45.7M | $44.7M | |
Gross Profit | $28.6M | $35.3M | $37.2M | $35.1M | $27M | |
Gross Profit Margin | 40.55% | 40.21% | 41.86% | 43.44% | 37.7% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $22.2M | $26.7M | $27.2M | $27.4M | $26.7M | |
Other Inc / (Exp) | $528K | $114K | -$133K | $755K | -$1.4M | |
Operating Expenses | $22.2M | $26.7M | $27.2M | $27.4M | $26.7M | |
Operating Income | $6.4M | $8.6M | $10M | $7.7M | $335K | |
Net Interest Expenses | $260K | $265K | $631K | $305K | $230K | |
EBT. Incl. Unusual Items | $6.7M | $8.4M | $9.2M | $8.2M | -$1.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.8M | $1.7M | $2.2M | $2.3M | -$332K | |
Net Income to Company | $4.9M | $6.7M | $7M | $5.8M | -$955K | |
Minority Interest in Earnings | $18K | -$328K | -$18K | $59K | $13K | |
Net Income to Common Excl Extra Items | $5M | $6.4M | $7M | $5.9M | -$942K | |
Basic EPS (Cont. Ops) | $0.36 | $0.47 | $0.51 | $0.44 | -$0.07 | |
Diluted EPS (Cont. Ops) | $0.36 | $0.46 | $0.51 | $0.44 | -$0.07 | |
Weighted Average Basic Share | $13.6M | $13.6M | $13.6M | $13.4M | $13.3M | |
Weighted Average Diluted Share | $13.6M | $13.7M | $13.7M | $13.5M | $13.3M | |
EBITDA | $10.5M | $12.6M | $14.1M | $12.7M | $3.3M | |
EBIT | $7M | $8.8M | $10.2M | $8.8M | -$737K | |
Revenue (Reported) | $70.6M | $87.7M | $88.9M | $80.8M | $71.7M | |
Operating Income (Reported) | $6.4M | $8.6M | $10M | $7.7M | $335K | |
Operating Income (Adjusted) | $7M | $8.8M | $10.2M | $8.8M | -$737K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $272.7M | $335M | $363.8M | $347M | $297.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $164.9M | $203.2M | $212.2M | $198.7M | $180M | |
Gross Profit | $107.8M | $131.8M | $151.6M | $148.2M | $117.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $80.1M | $100.4M | $105M | $107M | $106.9M | |
Other Inc / (Exp) | -$6.5M | -$2.8M | $1.6M | -$1.8M | -$1.7M | |
Operating Expenses | $80.1M | $100.4M | $105M | $107M | $106.9M | |
Operating Income | $27.7M | $31.4M | $46.5M | $41.2M | $10.6M | |
Net Interest Expenses | $986K | $983K | $2.2M | $2M | $764K | |
EBT. Incl. Unusual Items | $20.2M | $27.6M | $45.9M | $37.4M | $8.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $7.7M | $5.4M | $9M | $12.5M | $5.1M | |
Net Income to Company | $12.5M | $22.2M | $36.9M | $24.9M | $3M | |
Minority Interest in Earnings | -$15K | -$568K | -$180K | -$226K | $31K | |
Net Income to Common Excl Extra Items | $12.4M | $21.6M | $36.7M | $24.6M | $3.1M | |
Basic EPS (Cont. Ops) | $0.91 | $1.59 | $2.69 | $1.82 | $0.23 | |
Diluted EPS (Cont. Ops) | $0.91 | $1.58 | $2.69 | $1.81 | $0.23 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $34.2M | $44.2M | $64.2M | $56.6M | $26.5M | |
EBIT | $21.4M | $28.9M | $48.8M | $41M | $10.6M | |
Revenue (Reported) | $272.7M | $335M | $363.8M | $347M | $297.5M | |
Operating Income (Reported) | $27.7M | $31.4M | $46.5M | $41.2M | $10.6M | |
Operating Income (Adjusted) | $21.4M | $28.9M | $48.8M | $41M | $10.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $70.6M | $87.7M | $88.9M | $80.8M | $71.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $42M | $52.4M | $51.7M | $45.7M | $44.7M | |
Gross Profit | $28.6M | $35.3M | $37.2M | $35.1M | $27M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $22.2M | $26.7M | $27.2M | $27.4M | $26.7M | |
Other Inc / (Exp) | $528K | $114K | -$133K | $755K | -$1.4M | |
Operating Expenses | $22.2M | $26.7M | $27.2M | $27.4M | $26.7M | |
Operating Income | $6.4M | $8.6M | $10M | $7.7M | $335K | |
Net Interest Expenses | $260K | $265K | $631K | $305K | $230K | |
EBT. Incl. Unusual Items | $6.7M | $8.4M | $9.2M | $8.2M | -$1.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.8M | $1.7M | $2.2M | $2.3M | -$332K | |
Net Income to Company | $4.9M | $6.7M | $7M | $5.8M | -$955K | |
Minority Interest in Earnings | $18K | -$328K | -$18K | $59K | $13K | |
Net Income to Common Excl Extra Items | $5M | $6.4M | $7M | $5.9M | -$942K | |
Basic EPS (Cont. Ops) | $0.36 | $0.47 | $0.51 | $0.44 | -$0.07 | |
Diluted EPS (Cont. Ops) | $0.36 | $0.46 | $0.51 | $0.44 | -$0.07 | |
Weighted Average Basic Share | $13.6M | $13.6M | $13.6M | $13.4M | $13.3M | |
Weighted Average Diluted Share | $13.6M | $13.7M | $13.7M | $13.5M | $13.3M | |
EBITDA | $10.5M | $12.6M | $14.1M | $12.7M | $3.3M | |
EBIT | $7M | $8.8M | $10.2M | $8.8M | -$737K | |
Revenue (Reported) | $70.6M | $87.7M | $88.9M | $80.8M | $71.7M | |
Operating Income (Reported) | $6.4M | $8.6M | $10M | $7.7M | $335K | |
Operating Income (Adjusted) | $7M | $8.8M | $10.2M | $8.8M | -$737K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $98.4M | $84.3M | $88.6M | $84M | $79.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $45.3M | $58.3M | $60.1M | $56.4M | $51.2M | |
Inventory | $62.3M | $76.4M | $84.7M | $88.1M | $84.2M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $15.8M | $15.9M | $18.5M | $14.5M | $17.1M | |
Total Current Assets | $221.9M | $234.9M | $251.8M | $243.1M | $236.9M | |
Property Plant And Equipment | $96.8M | $109M | $111.5M | $117.6M | $103.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $31.1M | $45.8M | $45.5M | $45.7M | $46.8M | |
Other Intangibles | $32M | $52.4M | $48.2M | $44.6M | $41.8M | |
Other Long-Term Assets | $20.1M | $19.7M | $19.7M | $20.5M | $21.5M | |
Total Assets | $401.9M | $461.9M | $476.7M | $471.6M | $450.9M | |
Accounts Payable | $10.5M | $14.9M | $13.8M | $11.7M | $9.9M | |
Accrued Expenses | $24.6M | $31.9M | $29.4M | $26.7M | $24.8M | |
Current Portion Of Long-Term Debt | $18K | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $4M | $4.6M | $4.2M | $4M | $4M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $47.5M | $64.6M | $64.3M | $61.6M | $53M | |
Long-Term Debt | $40.6M | $60.7M | $60.8M | $31.9M | $31.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $144M | $184.8M | $170.2M | $141.6M | $129.1M | |
Common Stock | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M | |
Other Common Equity Adj | -$32.7M | -$35M | -$40.9M | -$38.9M | -$48.9M | |
Common Equity | $257.8M | $277.1M | $306.5M | $329.8M | $322M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $34K | -$57K | -$25K | $83K | -$107K | |
Total Equity | $257.9M | $277M | $306.5M | $329.9M | $321.9M | |
Total Liabilities and Equity | $401.9M | $461.9M | $476.7M | $471.6M | $450.9M | |
Cash and Short Terms | $98.4M | $84.3M | $88.6M | $84M | $79.3M | |
Total Debt | $40.6M | $60.7M | $60.8M | $31.9M | $31.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $96.2M | $78.2M | $93.3M | $83M | $83.9M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $43.9M | $59.1M | $59.3M | $52.2M | $50.2M | |
Inventory | $64.3M | $79.4M | $87.4M | $89.7M | $83.9M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $15.3M | $18.2M | $17.4M | $16.1M | $18.1M | |
Total Current Assets | $219.6M | $234.9M | $257.4M | $241M | $241.4M | |
Property Plant And Equipment | $96.7M | $106.8M | $111.2M | $115.5M | $101.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $31.2M | $46M | $45.6M | $45.6M | $46.9M | |
Other Intangibles | $31.5M | $51.6M | $47.3M | $43.6M | $40.9M | |
Other Long-Term Assets | $19.6M | $18.6M | $19.3M | $20.6M | $22.9M | |
Total Assets | $398.6M | $457.8M | $480.8M | $466.2M | $453.8M | |
Accounts Payable | $9.3M | $12.2M | $11.2M | $10.8M | $9.8M | |
Accrued Expenses | $29.9M | $40.7M | $29.3M | $27.1M | $25.8M | |
Current Portion Of Long-Term Debt | -- | -- | -- | $31.9M | -- | |
Current Portion Of Capital Lease Obligations | $3.8M | $4.6M | $4.1M | $4.1M | $4.1M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $44.4M | $58.6M | $60.4M | $91.5M | $53.5M | |
Long-Term Debt | $40.6M | $60.7M | $60.8M | -- | $31.5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $138M | $176M | $165.9M | $138.3M | $128.8M | |
Common Stock | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M | |
Other Common Equity Adj | -$34.3M | -$36.7M | -$39.4M | -$43.8M | -$45.2M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -$95K | $25K | -$27K | -$8K | $27K | |
Total Equity | $260.6M | $281.8M | $314.9M | $327.9M | $325M | |
Total Liabilities and Equity | $398.6M | $457.8M | $480.8M | $466.2M | $453.8M | |
Cash and Short Terms | $96.2M | $78.2M | $93.3M | $83M | $83.9M | |
Total Debt | $40.6M | $60.7M | $60.8M | $31.9M | $31.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $10.8M | $20.4M | $36.6M | $26M | $9.8M | |
Depreciation & Amoritzation | $12.5M | $15M | $15.4M | $15.6M | $15.8M | |
Stock-Based Compensation | $1.4M | $2.2M | $2.4M | $2.3M | $971K | |
Change in Accounts Receivable | -$753K | -$8M | -$4.8M | $3.8M | $3.2M | |
Change in Inventories | $3M | -$8.6M | -$11.9M | -$4.9M | $2.1M | |
Cash From Operations | $35.3M | $33.5M | $33M | $45.9M | $19.8M | |
Capital Expenditures | $22.9M | $17.1M | $21.3M | $15.2M | $9.2M | |
Cash Acquisitions | $156K | -$47.2M | -- | -- | -$4.4M | |
Cash From Investing | -$21.8M | -$64M | -$20.8M | -$15.1M | -$12.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $20M | -- | -- | -- | |
Long-Term Debt Repaid | -$3.5M | -$18K | -- | -$29M | -- | |
Repurchase of Common Stock | -- | -- | -$2.7M | -$5.9M | -$7.8M | |
Other Financing Activities | -$1.5M | -$1.2M | -$892K | -$1M | -$1.6M | |
Cash From Financing | -$5M | $18.8M | -$3.6M | -$35.9M | -$9.4M | |
Beginning Cash (CF) | $86.9M | $98.4M | $84.3M | $88.6M | $84M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $8.5M | -$11.7M | $8.6M | -$5.1M | -$2.5M | |
Ending Cash (CF) | $98.4M | $84.3M | $88.6M | $84M | $79.3M | |
Levered Free Cash Flow | $12.4M | $16.5M | $11.7M | $30.7M | $10.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $4.9M | $6.7M | $7M | $5.8M | -$955K | |
Depreciation & Amoritzation | $3.5M | $3.8M | $3.9M | $3.9M | $4M | |
Stock-Based Compensation | $366K | $497K | $681K | $661K | $545K | |
Change in Accounts Receivable | $753K | -$1.5M | $1.2M | $3.1M | $1.8M | |
Change in Inventories | -$3.1M | -$3.8M | -$2.9M | -$2.9M | $227K | |
Cash From Operations | $5.6M | -$273K | $8.4M | $6.4M | $5.2M | |
Capital Expenditures | $5.7M | $4.3M | $3.5M | $2.6M | $1.5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$5.7M | -$4.3M | -$3.5M | -$2.2M | -$1.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$18K | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -$2.8M | -- | |
Other Financing Activities | -$957K | -$681K | -$845K | -$890K | -$109K | |
Cash From Financing | -$975K | -$681K | -$845K | -$3.6M | -$109K | |
Beginning Cash (CF) | $98.4M | $84.3M | $88.6M | $84M | $79.3M | |
Foreign Exchange Rate Adjustment | -$1.2M | -$907K | $622K | -$1.5M | $987K | |
Additions / Reductions | -$1.1M | -$5.2M | $4.1M | $528K | $3.6M | |
Ending Cash (CF) | $96.2M | $78.2M | $93.3M | $83M | $83.9M | |
Levered Free Cash Flow | -$123K | -$4.6M | $4.9M | $3.8M | $3.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $12.5M | $22.2M | $36.9M | $24.9M | $3M | |
Depreciation & Amoritzation | $12.8M | $15.3M | $15.4M | $15.6M | $15.9M | |
Stock-Based Compensation | $1.4M | $2.4M | $2.6M | $2.3M | $855K | |
Change in Accounts Receivable | $5M | -$10.3M | -$2M | $5.7M | $2M | |
Change in Inventories | -$1.6M | -$9.3M | -$11M | -$4.9M | $5.3M | |
Cash From Operations | $34.6M | $27.6M | $41.7M | $43.9M | $18.7M | |
Capital Expenditures | $25.4M | $15.6M | $20.5M | $14.2M | $8.1M | |
Cash Acquisitions | $156K | -$47.2M | -- | -- | -- | |
Cash From Investing | -$24.2M | -$62.6M | -$20M | -$13.8M | -$12.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$126K | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -$2.7M | -$8.7M | -$5.1M | |
Other Financing Activities | -$1.3M | -$890K | -$1.1M | -$1.1M | -$803K | |
Cash From Financing | -$1.4M | $19.1M | -$3.8M | -$38.7M | -$5.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $9M | -$15.8M | $17.9M | -$8.7M | $620K | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $9.3M | $12M | $21.3M | $29.6M | $10.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $4.9M | $6.7M | $7M | $5.8M | -$955K | |
Depreciation & Amoritzation | $3.5M | $3.8M | $3.9M | $3.9M | $4M | |
Stock-Based Compensation | $366K | $497K | $681K | $661K | $545K | |
Change in Accounts Receivable | $753K | -$1.5M | $1.2M | $3.1M | $1.8M | |
Change in Inventories | -$3.1M | -$3.8M | -$2.9M | -$2.9M | $227K | |
Cash From Operations | $5.6M | -$273K | $8.4M | $6.4M | $5.2M | |
Capital Expenditures | $5.7M | $4.3M | $3.5M | $2.6M | $1.5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$5.7M | -$4.3M | -$3.5M | -$2.2M | -$1.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$18K | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -$2.8M | -- | |
Other Financing Activities | -$957K | -$681K | -$845K | -$890K | -$109K | |
Cash From Financing | -$975K | -$681K | -$845K | -$3.6M | -$109K | |
Beginning Cash (CF) | $98.4M | $84.3M | $88.6M | $84M | $79.3M | |
Foreign Exchange Rate Adjustment | -$1.2M | -$907K | $622K | -$1.5M | $987K | |
Additions / Reductions | -$1.1M | -$5.2M | $4.1M | $528K | $3.6M | |
Ending Cash (CF) | $96.2M | $78.2M | $93.3M | $83M | $83.9M | |
Levered Free Cash Flow | -$123K | -$4.6M | $4.9M | $3.8M | $3.7M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.